SCHEMBL24752687

SCHEMBL24752687

c1ccc(-c2nc(-c3ccc(-c4ccc(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)cc4)c4ccccc34)cc(-c3cc4ccccc4c4ccccc34)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ PTGER4 P35408 1/20 0.36
▸ TSPO P30536 1/20 0.33
▸ CYP11B1 P15538 1/20 0.33
▸ KMT2A Q03164 4/20 0.32
▸ MEN1 O00255 3/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ NTSR1 P30989 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ GPR84 Q9NQS5 1/20 0.32
▸ NPY5R Q15761 1/20 0.31
▸ AVPR1A P37288 1/20 0.31
▸ HDAC4 P56524 1/20 0.31
▸ PIK3CA P42336 1/20 0.30
▸ IL1R1 P14778 1/20 0.30
▸ ABCG2 Q9UNQ0 2/20 0.30
▸ PTGES O14684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26431886 0.92 KDM4E (0.41) L3MBTL1KDM4EATMCYP11B1KMT2A
SCHEMBL24752422 0.91 KDM4E (0.43) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL24752562 0.91 KDM4E (0.43) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL24752518 0.91 KDM4E (0.43) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL24752059 0.91 KDM4E (0.43) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL24753861 0.91 KDM4E (0.43) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL24752512 0.90 KDM4E (0.40) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL24752513 0.89 KDM4E (0.41) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL24787753 0.89 KMT2A (0.40) L3MBTL1KDM4EATMPTGER4TSPO
SCHEMBL24752184 0.89 KMT2A (0.40) L3MBTL1KDM4EATMPTGER4TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-04-27 — — US disclosed
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-04-27 — — US disclosed
EP-4101851-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE Idemitsu Kosan Co., Ltd (JP) 2022-12-14 — — EP disclosed
EP-4101847-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE Idemitsu Kosan Co., Ltd (JP) 2022-12-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, EPCAM, TMEM109 L3MBTL1 1434/4885KDM4E 3098/4885ATM 2552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback